Lin Shan C, Singh Kuldev, Jampel Henry D, Hodapp Elizabeth A, Smith Scott D, Francis Brian A, Dueker David K, Fechtner Robert D, Samples John S, Schuman Joel S, Minckler Don S
Ophthalmology. 2007 Oct;114(10):1937-49. doi: 10.1016/j.ophtha.2007.07.005.
To evaluate the current published literature on the use of optic nerve head (ONH) and retinal nerve fiber layer (RNFL) measurement devices in diagnosing open-angle glaucoma and detecting progression.
A search of peer-reviewed literature was conducted on February 15, 2006 in PubMed and the Cochrane Library for the period January 2003 to February 2006. The search was limited to studies of adults in English-language journals and yielded 442 citations. The panel reviewed the abstracts of these articles and selected 159 articles of possible clinical relevance for review. Of these 159 full-text articles, 82 were determined to be relevant for the first author and methodologist to review and rate according to the quality of evidence.
There were no studies classified as having the highest level of evidence (level I). The ONH and RNFL imaging instruments reviewed in this assessment were determined to be highly effective in distinguishing eyes with glaucomatous visual field (VF) loss from normal eyes without VF loss, based on level II evidence. In addition, some studies demonstrated that parameters from ONH or RNFL imaging predicted the development of VF defects among glaucoma suspects. Studies on detecting glaucoma progression showed that although there was often agreement on progression between the structural and functional (VF) tests, a significant proportion of glaucoma patients progressed by either the structural or the functional test alone.
The ONH and RNFL imaging devices provide quantitative information for the clinician. Based on studies that have compared the various available technologies directly, there is no single imaging device that outperforms the others in distinguishing patients with glaucoma from controls. Ongoing advances in imaging and related software, as well as the impracticalities associated with obtaining and assessing optic nerve stereophotographs, have made imaging increasingly important in many practice settings. The information obtained from imaging devices is useful in clinical practice when analyzed in conjunction with other relevant parameters that define glaucoma diagnosis and progression.
评估目前已发表的关于使用视神经乳头(ONH)和视网膜神经纤维层(RNFL)测量设备诊断开角型青光眼及检测病情进展的文献。
于2006年2月15日在PubMed和Cochrane图书馆检索2003年1月至2006年2月期间的同行评审文献。检索限于英文期刊中关于成人的研究,共获得442条引用文献。该小组审查了这些文章的摘要,并挑选出159篇可能具有临床相关性的文章进行评审。在这159篇全文文章中,82篇被确定与第一作者和方法学家相关,需根据证据质量进行评审和评分。
没有被归类为具有最高证据水平(I级)的研究。根据II级证据,本次评估中所审查的ONH和RNFL成像仪器在区分有青光眼性视野(VF)缺损的眼睛与无VF缺损的正常眼睛方面被确定为非常有效。此外,一些研究表明,ONH或RNFL成像的参数可预测青光眼可疑患者VF缺损的发生。关于检测青光眼病情进展的研究表明,虽然结构和功能(VF)测试之间在病情进展方面常常存在一致性,但相当一部分青光眼患者仅通过结构或功能测试之一就出现了病情进展。
ONH和RNFL成像设备为临床医生提供了定量信息。基于直接比较各种现有技术的研究,在区分青光眼患者与对照者方面,没有一种成像设备优于其他设备。成像及相关软件的不断进步,以及获取和评估视神经立体照片的不切实际性,使得成像在许多临床实践环境中变得越来越重要。当与定义青光眼诊断和病情进展的其他相关参数结合分析时,从成像设备获得的信息在临床实践中是有用的。